US Stock MarketDetailed Quotes

Rockwell Medical (RMTI)

Watchlist
  • 0.9502
  • -0.0073-0.76%
Close Jan 15 15:55 ET
  • 0.9502
  • 0.00000.00%
Post 16:10 ET
37.44MMarket Cap-5.28P/E (TTM)

Rockwell Medical (RMTI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-43.75%15.93M
-37.79%16.07M
-16.59%18.91M
21.38%101.49M
11.64%24.67M
19.12%28.32M
42.88%25.83M
15.29%22.68M
14.84%83.61M
14.39%22.09M
Operating revenue
-43.75%15.93M
-37.79%16.07M
-16.59%18.91M
21.38%101.49M
11.64%24.67M
19.12%28.32M
42.88%25.83M
15.29%22.68M
14.84%83.61M
14.39%22.09M
Cost of revenue
-38.15%13.66M
-36.25%13.57M
-19.07%15.87M
12.14%84.01M
9.42%21.03M
2.36%22.08M
24.84%21.28M
14.90%19.61M
8.98%74.91M
13.26%19.22M
Gross profit
-63.58%2.27M
-44.99%2.5M
-0.72%3.04M
100.87%17.48M
26.52%3.63M
183.33%6.24M
340.46%4.55M
17.89%3.06M
113.49%8.7M
22.65%2.87M
Operating expense
-10.39%3.86M
-4.54%3.85M
0.32%4.4M
9.77%16.88M
21.45%4.15M
9.24%4.3M
1.08%4.04M
8.99%4.39M
-26.29%15.37M
-20.65%3.42M
Selling and administrative expenses
-10.39%3.86M
-4.54%3.85M
0.73%4.4M
18.15%16.86M
27.70%4.15M
24.91%4.3M
5.49%4.04M
16.60%4.37M
-19.57%14.27M
-21.71%3.25M
-Selling and marketing expense
-26.86%531K
-2.39%572K
19.70%711K
29.36%2.75M
55.82%843K
30.58%726K
10.57%586K
19.28%594K
1.48%2.13M
54.13%541K
-General and administrative expense
-7.05%3.33M
-4.90%3.28M
-2.25%3.69M
16.19%14.11M
22.08%3.31M
23.81%3.58M
4.67%3.45M
16.18%3.78M
-22.39%12.14M
-28.72%2.71M
Research and development costs
--0
--0
--0
-98.28%19K
-99.40%1K
--0
--0
-93.53%18K
-64.51%1.11M
7.69%168K
Operating profit
-181.82%-1.58M
-361.94%-1.35M
-2.72%-1.36M
109.12%608K
5.12%-519K
211.46%1.94M
117.40%515K
7.22%-1.32M
60.25%-6.67M
72.18%-547K
Net non-operating interest income expense
15.44%-230K
7.17%-207K
48.16%-211K
44.40%-1.16M
75.61%-260K
23.38%-272K
35.55%-223K
-26.01%-407K
-9.83%-2.09M
-169.19%-1.07M
Non-operating interest income
83.33%55K
666.67%69K
175.00%66K
-56.40%92K
-30.95%29K
-46.43%30K
-81.63%9K
-62.50%24K
539.39%211K
--42K
Non-operating interest expense
-5.63%285K
18.97%276K
-35.73%277K
-45.50%1.25M
-73.92%289K
-26.52%302K
-41.27%232K
11.37%431K
18.85%2.3M
158.28%1.11M
Other net income (expense)
61K
25.49%64K
56K
-76.95%74K
-77.23%23K
51K
7,925.00%321K
101K
Gain on sale of security
--61K
25.49%64K
--56K
-76.95%74K
-77.23%23K
----
--51K
----
7,925.00%321K
--101K
Income before tax
-205.35%-1.75M
-534.99%-1.49M
12.48%-1.52M
94.31%-480K
50.00%-756K
188.89%1.66M
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
Income tax
Net income
-205.35%-1.75M
-534.99%-1.49M
12.48%-1.52M
94.31%-480K
50.00%-756K
188.89%1.66M
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
Net income continuous Operations
-205.35%-1.75M
-534.99%-1.49M
12.48%-1.52M
94.31%-480K
50.00%-756K
188.89%1.66M
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
Minority interest income
Net income attributable to the parent company
-205.35%-1.75M
-534.99%-1.49M
12.48%-1.52M
94.31%-480K
50.00%-756K
188.89%1.66M
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
Preferred stock dividends
Other preferred stock dividends
101.33%302K
150K
Net income attributable to common stockholders
-205.35%-1.75M
-534.99%-1.49M
12.48%-1.52M
90.90%-782K
36.34%-1.06M
188.89%1.66M
110.38%343K
1.09%-1.73M
54.02%-8.59M
29.64%-1.66M
Basic earnings per share
-200.00%-0.05
-600.00%-0.05
33.33%-0.04
91.89%-0.03
20.00%-0.04
171.43%0.05
105.56%0.01
40.00%-0.06
71.76%-0.37
75.00%-0.05
Diluted earnings per share
-225.00%-0.05
-600.00%-0.05
33.33%-0.04
91.89%-0.03
20.00%-0.04
157.14%0.04
105.56%0.01
40.00%-0.06
71.76%-0.37
75.00%-0.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -43.75%15.93M-37.79%16.07M-16.59%18.91M21.38%101.49M11.64%24.67M19.12%28.32M42.88%25.83M15.29%22.68M14.84%83.61M14.39%22.09M
Operating revenue -43.75%15.93M-37.79%16.07M-16.59%18.91M21.38%101.49M11.64%24.67M19.12%28.32M42.88%25.83M15.29%22.68M14.84%83.61M14.39%22.09M
Cost of revenue -38.15%13.66M-36.25%13.57M-19.07%15.87M12.14%84.01M9.42%21.03M2.36%22.08M24.84%21.28M14.90%19.61M8.98%74.91M13.26%19.22M
Gross profit -63.58%2.27M-44.99%2.5M-0.72%3.04M100.87%17.48M26.52%3.63M183.33%6.24M340.46%4.55M17.89%3.06M113.49%8.7M22.65%2.87M
Operating expense -10.39%3.86M-4.54%3.85M0.32%4.4M9.77%16.88M21.45%4.15M9.24%4.3M1.08%4.04M8.99%4.39M-26.29%15.37M-20.65%3.42M
Selling and administrative expenses -10.39%3.86M-4.54%3.85M0.73%4.4M18.15%16.86M27.70%4.15M24.91%4.3M5.49%4.04M16.60%4.37M-19.57%14.27M-21.71%3.25M
-Selling and marketing expense -26.86%531K-2.39%572K19.70%711K29.36%2.75M55.82%843K30.58%726K10.57%586K19.28%594K1.48%2.13M54.13%541K
-General and administrative expense -7.05%3.33M-4.90%3.28M-2.25%3.69M16.19%14.11M22.08%3.31M23.81%3.58M4.67%3.45M16.18%3.78M-22.39%12.14M-28.72%2.71M
Research and development costs --0--0--0-98.28%19K-99.40%1K--0--0-93.53%18K-64.51%1.11M7.69%168K
Operating profit -181.82%-1.58M-361.94%-1.35M-2.72%-1.36M109.12%608K5.12%-519K211.46%1.94M117.40%515K7.22%-1.32M60.25%-6.67M72.18%-547K
Net non-operating interest income expense 15.44%-230K7.17%-207K48.16%-211K44.40%-1.16M75.61%-260K23.38%-272K35.55%-223K-26.01%-407K-9.83%-2.09M-169.19%-1.07M
Non-operating interest income 83.33%55K666.67%69K175.00%66K-56.40%92K-30.95%29K-46.43%30K-81.63%9K-62.50%24K539.39%211K--42K
Non-operating interest expense -5.63%285K18.97%276K-35.73%277K-45.50%1.25M-73.92%289K-26.52%302K-41.27%232K11.37%431K18.85%2.3M158.28%1.11M
Other net income (expense) 61K25.49%64K56K-76.95%74K-77.23%23K51K7,925.00%321K101K
Gain on sale of security --61K25.49%64K--56K-76.95%74K-77.23%23K------51K----7,925.00%321K--101K
Income before tax -205.35%-1.75M-534.99%-1.49M12.48%-1.52M94.31%-480K50.00%-756K188.89%1.66M110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M
Income tax
Net income -205.35%-1.75M-534.99%-1.49M12.48%-1.52M94.31%-480K50.00%-756K188.89%1.66M110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M
Net income continuous Operations -205.35%-1.75M-534.99%-1.49M12.48%-1.52M94.31%-480K50.00%-756K188.89%1.66M110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M
Minority interest income
Net income attributable to the parent company -205.35%-1.75M-534.99%-1.49M12.48%-1.52M94.31%-480K50.00%-756K188.89%1.66M110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M
Preferred stock dividends
Other preferred stock dividends 101.33%302K150K
Net income attributable to common stockholders -205.35%-1.75M-534.99%-1.49M12.48%-1.52M90.90%-782K36.34%-1.06M188.89%1.66M110.38%343K1.09%-1.73M54.02%-8.59M29.64%-1.66M
Basic earnings per share -200.00%-0.05-600.00%-0.0533.33%-0.0491.89%-0.0320.00%-0.04171.43%0.05105.56%0.0140.00%-0.0671.76%-0.3775.00%-0.05
Diluted earnings per share -225.00%-0.05-600.00%-0.0533.33%-0.0491.89%-0.0320.00%-0.04157.14%0.04105.56%0.0140.00%-0.0671.76%-0.3775.00%-0.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More